Systems biology-derived biomarkers to predict progression of renal function decline in type 2 diabetes

Diabetes Care

Volumn 40, Issue 3, 2017, Pages 391-397

  Mayer, Gert ^a   Heerspink, Hiddo J L ^b   Aschauer, Constantin ^c   Heinzel, Andreas ^d   Heinze, Georg ^c   Kainz, Alexander ^c   Sunzenauer, Judith ^c   Perco, Paul ^d   De Zeeuw, Dick ^b   Rossing, Peter ^e   Pena, Michelle ^b   Oberbauer, Rainer ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Emergentec Biodevelopment GmbH   (Austria)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHITINASE 3 LIKE PROTEIN 1; COLLAGENASE 3; GELATINASE A; GROWTH HORMONE 1; MATRILYSIN; NEUTROPHIL COLLAGENASE; PROTEIN TYROSINE KINASE; SCATTER FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CREATININE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE; MATRIX METALLOPROTEINASE; TNFRSF1A PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; CALIBRATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MIXED LINEAR REGRESSION MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STATISTICAL MODEL; SYSTEMS BIOLOGY; AGED; BLOOD; FOLLOW UP; GENETICS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; RISK FACTOR;

AGED; ALBUMINURIA; BIOMARKERS; BLOOD GLUCOSE; CHITINASE-3-LIKE PROTEIN 1; CREATININE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GROWTH HORMONE; HEPATOCYTE GROWTH FACTOR; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SYSTEMS BIOLOGY;

EID: 85019733460     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2202     Document Type: Article

References (25)

1. Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013;382:158-169
2. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009;20:1069-1077
3. Heinzel A, Mühlberger I, Stelzer G, et al. Molecular disease presentation in diabetic nephropathy. Nephrol Dial Transplant 2015; 30(Suppl. 4):iv17-iv25
4. Parving HH, Persson F, Rossing P. Microalbuminuria: A parameter that has changed diabetes care. Diabetes Res Clin Pract 2015;107:1-8
5. Heinzel A, Mühlberger I, Fechete R, Mayer B, Perco P. Functional molecular units for guiding biomarker panel design. Methods Mol Biol 2014;1159:109-133
6. Ju W, Nair V, Smith S, et al.; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 2015;7:316ra193
7. Schanstra JP, Zürbig P, Alkhalaf A, et al. Diagnosis and prediction of CKD progression by assessment of urinary peptides. J Am Soc Nephrol 2015;26:1999-2010
8. Pena MJ, de Zeeuw D, Mischak H, et al. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrol Dial Transplant 2015;30(Suppl. 4):iv86-iv95
9. Lambers Heerspink HJ, Oberbauer R, Perco P, et al. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine. Nephrol Dial Transplant 2015;30(Suppl. 4):iv105-iv112
10. Mayer P, Mayer B, Mayer G. Systems biology: building a useful model from multiple markers and profiles. Nephrol Dial Transplant 2012;27:3995-4002
11. Pena MJ, Heinzel A, Heinze G, et al. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes. PLoS One 2015;10:e0120995
12. Fechete R, Heinzel A, Soellner J, Perco P, Lukas A, Mayer B. Using information content for expanding human protein coding gene interaction networks. J Comput Sci Syst Biol 2013;6:073-082
13. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003;4:2
14. Sjølie AK, Klein R, Porta M, et al.; DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): A randomised placebo-controlled trial. Lancet 2008; 372:1385-1393
15. Packham DK, Wolfe R, Reutens AT, et al.; Collaborative Study Group. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol 2012;23: 123-130
16. Niewczas MA, Gohda T, Skupien J, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J AmSoc Nephrol 2012;23:507-515
17. Nowak N, Skupien J, Niewczas MA, et al. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in nonproteinuric patients with type 1 diabetes. Kidney Int 2016;89:459-467
18. Saulnier PJ, Gand E, Ragot S, et al.; SURDIAGENE Study Group. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care 2014;37:1425-1431
19. Thrailkill KM, Bunn RC, Moreau CS, et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 2007;30:2321-2326
20. Li SY, Huang PH, Yang AH, et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int 2014;86:358-369
21. Ban CR, Twigg SM, Franjic B, et al. Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Res Clin Pract 2010;87:335-341
22. Flaquer M, Franquesa M, Vidal A, et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012;55:2059-2068
23. Kusunoki H, Taniyama Y, Azuma J, et al. Telmisartan exerts renoprotective actions via peroxisome proliferator-Activated receptor-g/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade. Hypertension 2012;59: 308-316
24. Chitra PS, Swathi T, Sahay R, Reddy GB, Menon RK, Kumar PA. Growth hormone induces transforming growth factor-beta-induced protein in podocytes: implications for podocyte depletion and proteinuria. J Cell Biochem 2015; 116:1947-1956
25. Zurawska-Plaksej E, Lugowska A, Hetmań czyk K, Knapik-Kordecka M, Adamiec R, Piwowar A. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2. Biomarkers 2015; 20:52-57